GSK heritage companies have operated in Australia since 1886.
Australian branch of Wellcome Foundation registered as Burroughs Wellcome & Company (Australia), establishing a research-based industry in Australia.
Glaxo Boronia facility founded and expanded in various stages over the next four decades.
Poppy growing project starts in Tasmania and develops into one of Australia’s greatest agricultural and manufacturing success stories.
Wellcome Australia Medal, now the GlaxoSmithKline Award for Research Excellence is presented for the first time.
Merger between Beecham Laboratories and Smith, Kline & French to form SmithKline Beecham.
Merger between Glaxo and Burroughs Wellcome to form Glaxo Wellcome.
Merger between Glaxo Wellcome and SmithKline Beecham to form GlaxoSmithKline (GSK).
New ‘Australasia’ region formed, consisting of GSK Australia and New Zealand.
Paul Lirette commences as Area Director Australasia & General Manager Australia.
Deborah Waterhouse commences as General Manager Australia. GSK becomes a leader in skincare with the acquisition of Stiefel. GSK and Pfizer launch ViiV Healthcare, a company focused on delivering advances in treatment and care for HIV communities.
Geoff McDonald commences as General Manager Australia.
In March we acquired Novartis’s vaccines business (excluding influenza vaccines) and combined our Consumer Healthcare businesses to create a new company. We also sold our opiates business to Sun Pharma.